Genetic analysis of de novo CD5+ diffuse large B-cell lymphomas suggests an origin from a somatically mutated CD5+ progenitor B cell

Blood

Volumn 101, Issue 2, 2003, Pages 699-702

  Katzenberger, Tiemo ^a   Lohr, Andreas ^a,b   Schwarz, Stephan ^a,b   Dreyling, Martin ^a,b   Schoof, Julia ^a,b   Nickenig, Christina ^a,b   Stilgenbauer, Stephan ^a,b   Kalla, Jörg ^a,b   Ott, M Michaela ^a,b   Müller Hermelink, Hans Konrad ^a,b   Ott, German ^a,b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; PROTEIN P16;

ARTICLE; B CELL LYMPHOMA; CELL STRUCTURE; CHROMOSOME 16; CHROMOSOME 18; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; GENE DELETION; GENE LOCUS; GENETIC ANALYSIS; HUMAN; INTERPHASE; KARYOTYPE; PREVALENCE; PRIORITY JOURNAL; SOMATIC MUTATION; STEM CELL; TRISOMY; TRISOMY 3;

EID: 0037438381     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-06-1726     Document Type: Article

References (25)

1. The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood. 1997;89:3909-3918.
2. Gatter KC, Warnke RA. Diffuse large B-cell lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW. Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:171-176.
3. Schlegelberger B, Zwingers T, Harder L, et al. Clinicopathogenetic significance of chromosomal abnormalities in patients with blastic peripheral B-cell lymphoma. Kiel-Wien-Lymphoma Study Group. Blood. 1999;94:3114-3120.
4. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403:503-511.
5. Matolcsy A, Chadburn A, Knowles DM. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct. Am J Pathol. 1995;147:207-216.
6. Nakamura N, Hashimoto Y, Kuze T, et al. Analysis of the immunoglobulin heavy chain gene variable region of CD5-positive diffuse large B-cell lymphoma. Lab Invest. 1999;79:925-933.
7. Yatabe Y, Nakamura S, Seto M, et al. Clinico-pathologic study of PRAD1/cyclin D1 overexpressing lymphoma with special reference to mantle cell lymphoma: a distinct molecular pathologic entity. Am J Surg Pathol. 1996;20:1110-1122.
8. Nakamura N, Kuze T, Hashimoto Y, et al. Analysis of the immunoglobulin heavy chain gene variable region of CD5-positive and -negative diffuse large B cell lymphoma. Leukemia. 2001;15:452-457.
9. + diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients. Blood. 2002;99:815-821.
10. Oka K, Ohno T, Kita K, et al. PRAD1 gene over-expression in mantle-cell lymphoma but not in other low-grade B-cell lymphomas, including extranodal lymphoma. Br J Haematol. 1994;86:786-791.
11. + diffuse large B-cell lymphomas express VH genes with somatic mutation. Blood. 1998;91:1145-1151.
12. Dohner H, Stilgenbauer S, Benner A, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med. 2000;343:1910-1916.
13. Muller-Hermelink HK, Zettl A, Pfeifer W, Ott G. Pathology of lymphoma progression. Histopathology. 2001;38:285-306.
14. Ott G, Katzenberger T, Greiner A, et al. The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type. Cancer Res. 1997;57:3944-3948.
15. Mitelman F. ISCIN 1995: an International System for Human Cytogenetic Nomenclature. Memphis, TN; S. Karger, Basel, Switzerland: 1995.
16. Dreyling MH, Bohlander SK, Le Beau MM, Olopade OI. Refined mapping of genomic rearrangements involving the short arm of chromosome 9 in acute lymphoblastic leukemias and other hematologic malignancies. Blood. 1995;86:1931-1938.
17. Stilgenbauer S, Winkler D, Ott G, et al. Molecular characterization of 11q deletions points to a pathogenic role of the ATM gene in mantle cell lymphoma. Blood. 1999;94:3262-3264.
18. Lichter P, Tang CJ, Call K, et al. High-resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones. Science. 1990;247:64-69.
19. Stilgenbauer S, Liebisch P, James MR, et al. Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-923.1 in lymphoproliferative disorders. Proc Natl Acad Sci U S A. 1996;93:11837-11841.
20. Küppers R, Zhao M, Rajewsky K, Hansmann ML. Detection of clonal B cell populations in paraffinembedded tissues by polymerase chain reaction. Am J Pathol. 1993;143:230-239.
21. Campbell MJ, Zelenetz AD, Levy S, Levy R. Use of family specific leader region primers for PCR amplification of the human heavy chain variable region gene repertoire. Mol Immunol. 1992;29:193-203.
22. Rosenwald A, Ott G, Krumdiek AK, et al. A biological role for deletions in chromosomal band 13q14 in mantle cell and peripheral T-cell lymphomas? Genes Chromosomes Cancer. 1999;26:210-214.
23. Stilgenbauer S, Nickolenko J, Wilhelm J, et al. Expressed sequences as candidates for a novel tumor suppressor gene at band 13q14 in B-cell chronic lymphocytic leukemia and mantle cell lymphoma. Oncogene. 1998;16:1891-1897.
24. Stankovic T, Stewart GS, Fegan C, et al. Ataxia telangiectasia mutated-deficient B-cell chronic lymphocytic leukemia occurs in pregerminal center cells and results in defective damage response and unrepaired chromosome damage. Blood. 2002;99:300-309.
25. Kröber A, Seiler T, Benner A, et al. VH mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood. 2002;100:1410-1416.